Safe engineering of CAR T cells for adoptive cell therapy of cancer using long‐term episomal gene transfer
Abstract Chimeric antigen receptor (CAR) T‐cell therapy is a new successful treatment for refractory B‐cell leukemia. Successful therapeutic outcome depends on long‐term expression of CAR transgene in T cells, which is achieved by delivering transgene using integrating gamma retrovirus (RV) or lenti...
Saved in:
| Main Authors: | Chuan Jin, Grammatiki Fotaki, Mohanraj Ramachandran, Berith Nilsson, Magnus Essand, Di Yu |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Springer Nature
2016-05-01
|
| Series: | EMBO Molecular Medicine |
| Subjects: | |
| Online Access: | https://doi.org/10.15252/emmm.201505869 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Plant Compounds Inhibit the Growth of W12 Cervical Precancer Cells Containing Episomal or Integrant HPV DNA; Tanshinone IIA Synergizes with Curcumin in Cervical Cancer Cells
by: Linda Saxe Einbond, et al.
Published: (2024-12-01) -
Self-replicating recombinant virus-like particles of lentivirus proliferating in glioblastoma cells and normal human macrophages
by: Herman D. Moshkoff, et al.
Published: (2024-11-01) -
Targeting EBV Episome for Anti-Cancer Therapy: Emerging Strategies and Challenges
by: Febri Gunawan Sugiokto, et al.
Published: (2025-01-01) -
基于episomal CRISPR/Cas9 载体的基因敲入方法
by: 邹征伟, et al.
Published: (2018-01-01) -
Autologous, lentivirus‐modified, T‐rapa cell “micropharmacies” for lysosomal storage disorders
by: Murtaza S Nagree, et al.
Published: (2022-03-01)